ELISA results reported that (Fig. 1e) in relation to the peripheral blood of healthy examiners, TGF-β1 content was increased and IFN-γ content was decreased in peripheral blood of glioma patients (both p < 0.05). The gene discussed is TGFB1; the disease is central nervous system cancer.